Global genome sequencing market is expected to rise to an estimated value of USD 47.97 billion by 2026 registering a substantial CAGR of 13.95% in the forecast period of 2019-2026. This rise in the market can be attributed to the rising government spending, rise in the applications of genomics and the declining sequencing costs.
The genome sequencing report includes a brief information regarding the market and explains the market trends in detail that can help the business operating in the industry to understand the market and strategize for their business expansion accordingly. The research report analyzes the market size, industry share, growth, key segments, CAGR and key drivers. The genome sequencing report firstly introduced the market basics, definitions, classifications, applications and market overview, product specifications, raw materials and so on. In the end, the genome sequencing report introduced new project SWOT analysis, investment feasibility analysis and investment return analysis.
Ask For Complimentary Sample PDF| Request At https://databridgemarketresearch.com/request-a-sample/?dbmr=global-genome-sequencing-market
Competitive Analysis: Global Genome Sequencing Market
Global genome sequencing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of genome sequencing market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Market Competitors: Global Genome Sequencing Market
Few of the major market competitors currently working in the genome sequencing market are Thermo Fisher Scientific, Illumina, Inc., QIAGEN, Eurofins Scientific, Agilent Technologies, Inc., Oxford Nanopore Technologies., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., BGI, Danaher., GENERAL ELECTRIC COMPANY, Eppendorf AG, Abbott, LI-COR, Inc., Siemens, PerkinElmer Inc., Macrogen Inc., DNASTAR, Geneious, Myriad Genetics, Inc., amongst others.
Increased funding and initiative by the government to promote genome sequencing and its varied applicability in numerous projects accelerates the growth of this market
Reduction in the costs of genome sequencing further boosts the growth of this market
Growing applicability of genomes in various areas including diagnosis, animal research, agriculture, drug discovery, food and beverages etc.
With changing environment of operations and advancements in technology, several new opportunities have been created thereby leading to the entry of new players and start-ups that would foster the growth of this market
Expensive and high cost of genome equipments
Lack of skilled professionals
Table of Contents
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
9. Industry Type
Segmentation: Global Genome Sequencing Market
By Product and Services
Systems & Software
Nucleic Acid Extraction & Purification
Drug Discovery & Development
Agriculture & Animal Research
By End User
Academic & Government Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Other End Users
Rest of South America
Rest of Europe
Rest of Asia-Pacific
Middle East and Africa
United Arab Emirates
Rest of Middle East and Africa
Key Developments in the Market:
In November 2018, Illumina Inc., the genome sequencing giants acquires Pacific Biosciences, a developer and manufacturer of gene sequencing. With this acquisition it would combine its own short genome/DNA sequencing with the long-read sequencing technology of Pacific Biosciences in order to maintain its dominant position in the genomes market, and continue to remain the market leader. With this, it would be able to enter into a new market especially in the areas of rare and undiagnosed diseases, thereby expanding its customer base and providing innovative solutions and services to its clients.
In June 2017, GATC Biotech AG, a leading company in genome sequencing was acquired by Eurofins, the global pioneering leader in bio-analytical testing including DNA, genome testing. With this acquisition Eurofins would expand its product portfolio and better serve its present and future clients by strengthening its genomics and genomic sequencing testing by acquiring the market leader in genomes.
Inquiry For Customize Report With Discount at : https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-genome-sequencing-market
Reasons to Purchase this Report
Current and future of global genome sequencing market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Data Bridge Market Research